Search

Search Constraints

You searched for: Author/Creator Li, Qiao‐Xin

Search Results

1. [F1–02–01]: DIAGNOSTIC AND PROGNOSTIC POWER OF FLUID AND NEUROIMAGING MARKERS OF PATHOLOGY AND NEURODEGENERATION: THE ALZHEIMER'S IMAGING, BIOMARKERS, AND LIFESTYLE (AIBL) STUDY OF AGEING EXPERIENCE. (1st July 2017)

2. [O1–06–04]: CSF P‐TAU IS CORRELATED WITH TAU PET, WHILE Aβ PET CORRELATES WITH Aβ1–42 AND THE T‐TAU/Aβ1–42 RATIO. (1st July 2017)

3. [P1–416]: CSF TOTAL TAU AS A BIOMARKER FOR NEURONAL INJURY IN ALZHEIMER's DISEASE: ALIGNING RATES OF CSF CHANGE WITH RATES OF HIPPOCAMPAL AND CORTICAL GRAY MATTER ATROPHY. (1st July 2017)

4. [P4–134]: INSULIN RESISTANCE IS ASSOCIATED WITH REDUCTIONS IN SPECIFIC COGNITIVE DOMAINS AND INCREASES IN CSF TAU IN COGNITIVELY NORMAL ADULTS. (1st July 2017)

6. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Issue 11 (7th September 2019)

7. A phase 1b open‐label study of sodium selenate as a disease‐modifying treatment for possible behavioral variant frontotemporal dementia. Issue 1 (5th May 2022)

9. Cerebrospinal fluid biomarker levels are not affected by aspiration or gravity drip extraction methods in Alzheimer's disease: The AIBL study: Biomarkers (non‐neuroimaging): Method development and validation. (7th December 2020)

10. Cerebrospinal fluid levels of fatty acid–binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals. Issue 1 (4th December 2022)